Redefining the Autoimmune ILD Journey: From Early Risk Recognition to Long Term Care
Objectives:
Autoimmune diseases are a major cause of interstitial lung disease (ILD), with pulmonary fibrosis driving morbidity and mortality. This session will examine risk identification, key clinical and radiological signals of progression, and translation of guidelines into personalised care, concluding with emerging concepts and innovations shaping the future management of autoimmune ILD.
| Agenda - Saturday 31 October | |
|---|---|
|
|
Chairperson: Prof Shin-Seok Lee
|
|
1250-1300
|
Opening and welcome remarks Prof Shin-Seok Lee |
|
1300-1320
|
Pulmonary fibrosis in autoimmune patients: who is at risk? Prof Andrea Low |
|
1320-1340
|
From Guidelines to the Individual Patient: Optimising Management of Autoimmune ILD Prof Anna Hoffman-Vold |
|
1340-1400
|
Shaping the future of autoimmune-ILD Prof Mandana Nikpour |
|
1400-1415
|
|
|
1415-1420
|
Closing remarks Prof Shin-Seok Lee |
